Innolife Co., Ltd.
π¨π³China
- Country
- π¨π³China
- Ownership
- Private, Subsidiary
- Established
- 2014-08-18
- Employees
- -
- Market Cap
- -
- Website
- http://www.innolife.com.cn
Clinical Trials
1
Active:0
Completed:0
Trial Phases
1 Phases
Phase 2:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (1 trials with phase data)β’ Click on a phase to view related trials
Phase 2
1 (100.0%)Study to Evaluate Effects of INL1 in Patients With Heart Failure and Reduced Ejection Fraction
- First Posted Date
- 2019-03-14
- Last Posted Date
- 2022-03-31
- Lead Sponsor
- Innolife Co., Ltd.
- Target Recruit Count
- 200
- Registration Number
- NCT03875183
- Locations
- πΊπΈ
UCLA School of Medicine, Torrance, California, United States
πΊπΈInnovative Research of West Florida, Inc., Clearwater, Florida, United States
πΊπΈUniversal Axon Clinical Research, Doral, Florida, United States
News
No news found